GHRH analogues & GH secretagogues
Modified GRF (1-29) / Ipamorelin
Research use only. For laboratory research use only. Not for human or veterinary use. Not a drug, food, cosmetic or medical device.
Unit pricing
1-4 unitsR799.00per unit
5-9 unitsR719.10per unit
10+ unitsR599.25per unit
Specification
| Name | Modified GRF (1-29) / Ipamorelin |
|---|---|
| Synonyms | Lyophilised blend: Modified GRF (1-29) 5 mg + Ipamorelin 5 mg |
| Modified GRF (1-29), 5 mg | CAS 863288-34-0 |
| Ipamorelin, 5 mg | CAS 170851-70-4 |
| Quantity per vial | 10 mg |
| Form | Lyophilised powder, requires reconstitution |
| Storage | -20 °C, desiccated, protected from light |
Description
Multi-component lyophilised preparation. Modified GRF (1-29): GHRH(1-29) amide with D-Ala2, Gln8, Ala15 and Leu27 substitutions for DPP-4 and oxidative stability. GHRH receptor agonist. Ipamorelin: Pentapeptide (Aib-His-D-2Nal-D-Phe-Lys-NH2). Selective agonist of the ghrelin receptor GHS-R1a.
Supplied as a lyophilised powder in a sealed glass vial. Requires reconstitution in an appropriate solvent prior to use. Store at -20 °C, desiccated and protected from light.
Batch certificate of analysis
This size has not yet been independently tested. Contact us before ordering if your work requires a report.